Bausch & Lomb price to book ratio BLCO

Market value divided by the book value of the company's net assets, since 2022.

Today, Oct 23, 2026: 1.0×
4-year median: 0.9×
Against its 4-year history: 90th; percentile: 0 is its lowest day, 100 its highest
4-year range: 0.6× to 1.1×
Peer median: 3.6×

Bausch & Lomb's price to book ratio is 1.0× as of Oct 23, 2026.

That is above its 4-year median of 0.9×, higher than on 90% of days in the last 4 years.

Over that time it ranged from 0.6× in Apr 2025 to 1.1× in Oct 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 3.6×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	1.0×	0.8×	1.0×
2025	0.9×	0.6×	0.9×
2024	1.0×	0.7×	1.1×
2023	0.9×	0.8×	1.0×
2022	0.8×	0.7×	0.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.

Company	Price to book ratio
BLCOBausch & Lomb	1.0×
MMSIMerit Medical Systems	3.3×
MSAMSA Safety	5.0×
HAEHaemonetics	6.4×
VNTVontier	3.9×
BMIBadger Meter	6.4×
ICUIICU Medical	1.9×
NVSTEnvista	1.2×
PODDInsulet	7.3×
GMEDGlobus Medical	2.3×
ALGNAlign Technology	2.6×
Peer median	3.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Bausch & Lomb

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.